The effect of exogenous surfactant replacement therapy on lung function

Area of Science:

• Neonatal respiratory medicine
• Pediatric pulmonology

Background:

• Premature birth often leads to respiratory distress syndrome (RDS).
• Exogenous surfactant replacement therapy is a standard treatment for RDS, reducing mortality and morbidity.

Purpose of the Study:

• To review existing data on the effects of exogenous surfactant replacement therapy on infant lung function.
• To assess the variability in the timing and magnitude of these effects.

Main Methods:

• Systematic review of existing studies on surfactant replacement therapy.
• Analysis of factors influencing the efficacy of surfactant therapy, including surfactant type, administration timing, and gestational age.

Main Results:

• Surfactant replacement therapy improves lung compliance, with variable timing and magnitude.
• Natural surfactants show a more rapid effect than artificial ones.
• Therapy as prophylaxis may yield different results than rescue therapy.
• Preliminary data suggest long-term improvements in lung function, including lower airway resistance and higher specific conductance.

Conclusions:

• Exogenous surfactant replacement therapy is effective in improving infant lung function.
• The efficacy is influenced by surfactant type, administration strategy, and gestational age.
• Emerging evidence indicates potential long-term benefits in reducing chronic respiratory morbidity in premature infants.